QIAGEN N.V. Expense Breakdown
No Expense Breakdown for QGEN on this site yet.
- 2025-12-31: Reportable $790.50M.
- 2024-12-31: Reportable $1.01B.
- 2023-12-31: Reportable $731.62M.
Source checked: the stored Expense Breakdown page for QGEN.
Expenses by product
Cost of sales: each year (12 month)
| Fiscal year end | Reportable |
|---|
| 2025-12-31 | $790.50M |
|---|
| 2024-12-31 | $1.01B |
|---|
| 2023-12-31 | $731.62M |
|---|
Income Tax Expense (Benefit): each year (12 month)
| Fiscal year end | Reportable |
|---|
| 2025-12-31 | $65.39M |
|---|
| 2024-12-31 | $37.56M |
|---|
| 2023-12-31 | $88.51M |
|---|
Operating expenses: each year (12 month)
| Fiscal year end | Reportable |
|---|
| 2025-12-31 | $833.64M |
|---|
| 2024-12-31 | $869.64M |
|---|
| 2023-12-31 | $823.75M |
|---|